ob0002cd1.4 | Case Discussions: Complex Clinical Cases 1 | OU2020
Dimitriadis Georgios K
, Dimitri Federica
, Bate Danielle
, Leca Bianca
, Davasgaium Allan
, Tripathi Gyanendra
, Miras Alexander D
, Rubino Francesco
, Christian Mark
, Randeva Harpal S
Aims: Liraglutide 3 mg once daily is an approved, prescription injectable Glucagon Like Peptide-1 receptor agonist that, when used with a low-calorie diet and increased physical activity, can reduce excess weight in patients with obesity. MiRNAs are small non-coding single stranded RNAs that regulate gene expression post-transcriptionally by inhibiting their mRNA target translation into proteins. MiRNAs can be secreted in the blood stream and affect the molecular pathways of d...